Although persistent AXL/GAS6 co-overexpression and acquired MERTK and KDR overexpression did not accelerate tumor xenograft growth rate, other concurrent phenotypic changes might nonetheless bear on disease progression. This evidence concerns the gene KDR and neoplasm.